ICML: International Conference on Malignant Lymphoma

Conference Coverage

R2-CHOP doesn’t improve survival in DLBCL

LUGANO, SWITZERLAND – The ROBUST trial is the latest in a long line of studies that failed to show improvement in outcomes with the addition of a...

Conference Coverage

Pembrolizumab takes on r/r PMBCL

LUGANO, SWITZERLAND – Keynote 170 investigators are enrolling adults with relapsed/refractory PMBCL who are either ineligible for ASCT following...

Pages